# INOVIO Announces Pricing of Approximately $75 Million Public Offering

- Source: PR Newswire M&A
- Published: 2026-11-06T04:18:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/inovio-announces-pricing-of-approximately-75-million-public-offering-302931699.html
- Canonical: https://groundlevelnews.com/story/inovio-announces-pricing-of-approximately-75-million-public-offering-4d5198/

PLYMOUTH MEETING, Pa., Nov. 5, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced the...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._
